- Division of Physiological and Pathological Sciences – DPPS
- Infectious Diseases and Microbiology – IDM
- Study Section:
- Exploration of Antimicrobial Therapeutics and Resistance – ZRG1 IDM-Y 82
Dr. Susan Daum (also known as Dr. Boyle-Vavra) serves as the Scientific Review Officer for CSR’s ZRG1-IDM Y 82 special emphasis panel as of October 2016.
This panel reviews R03 and R21 applications that are concerned with the identification of novel antibacterial, antifungal, antiparasitic, and antiviral agents that prevent and treat infectious diseases as well as the study of the evolution, mechanisms, and transmission of resistance. Dr. Daum obtained her Ph.D. in microbiology and immunology at Northwestern University in 1994 where she studied Neisseria gonorrhoeae. She then conducted studies at the University of Chicago from 1994 to 2016 where she investigated the bacterial pathogen Staphylococcus aureus, a major cause of skin infection and various invasive life threatening syndromes. Her studies as a Research Professor and Director of the MRSA Research Center Laboratory primarily focused on unraveling molecular mechanisms that underlie and control resistance to antibiotics with a secondary emphasis on pathogenesis and vaccines for combatting Staph aureus infection.